Abstract
An autoradiographic study of labeled mazindol binding to presumed dopamine (DA) uptake sites in the striatum was done in 7 Parkinson (PD), 6 Alzheimer (AD), 1 Huntington disease (HD), and 4 neurologically normal cases. Large and significant decreases of specific binding were found in PD in both caudate (to 32% of control) and putamen (to 16%), with no significant effect in AD or HD. Nonspecific binding was a large proportion of total binding in all cases. In the 12 cases where both binding data and DA levels were available, they showed highly significant linear correlations in both caudate and putamen. Autoradiographic studies on D1, D2, and muscarinic binding sites in the PD, AD and control striata revealed no significant group differences.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.